Senzime AB
You cannot register anymore for this webinar

Key Learning Objectives

  • How quantitative train-of-four monitoring can help tailor sugammadex dosing to individual patient needs.
  • Evidence indicating that a majority of patients receive an improper dose—some too much, others too little.
  • The potential adverse events associated with sugammadex use and strategies to mitigate these risks.
  • Best practices and real-world applications from both U.K. and U.S. experts to optimize patient safety.
Moderator
Michael Noble
VP, Global Marketing, Senzime

Presenters
Dr. Ross Renew (U.S)
Dr. Grant Rodney (U.K.)

Share this webinar